Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection
Publication Type:
Journal Article
Authors:
Graham R. Foster;
Stephen Pianko;
Brown, Ashley;
Forton, Daniel;
Nahass, Ronald G.;
George, Jacob;
Barnes, Eleanor;
Brainard, Diana M.;
Massetto, Benedetta;
Lin, Ming;
Han, Bin;
McHutchison, John G.;
Subramanian, G. Mani;
Cooper, Curtis;
Agarwal, Kosh;
BOSON Study GroupSource:
Gastroenterology, Volume 149, Issue 6, p.1462-1470 (2015)
Keywords:
Adult,
Aged,
Antiviral Agents,
BOSON,
Drug Administration Schedule,
Drug Therapy, Combination,
Female,
Genotype,
Hepacivirus,
hepatitis C virus,
Hepatitis C, Chronic,
Humans,
Interferon-alpha,
Liver Cirrhosis,
Male,
Middle Aged,
Nucleotide Analog,
peginterferon,
Ribavirin,
RNA, Viral,
Severity of Illness Index,
sofosbuvir,
Time Factors,
Treatment Outcome,
Viral Load
